Skip to main content

Table 1 Comparison between the 2 groups regarding demographic and laboratory findings

From: Vascular endothelial growth factor in relation to the development of hepatocellular carcinoma in hepatitis C virus patients treated by direct-acting antivirals

  HCV group (n = 25) HCC group (n = 25) P value
Gender#
 Male 17 (50) 17 (50) 1.00
 Female 8 (50) 8 (50)  
Age (years) 58.6 ± 4.4* 59 ± 4.2* 0.74
BMI 20 (19–22)** 24 (22–25)** < 0.001
Hemoglobin (gm/dl) 13 (11.75–15)** 9.54 ± 1.33* < 0.001
Platelets (103/Ul) 220 (153.5–240)** 89.8 ± 17.76* < 0.001
Bilirubin (mg/dl) 0.8 (0.7–0.95)** 2.4 (1.9–3.9)** < 0.001
Albumin (g/dl) 3.82 ± 0.34* 2.99 ± 0.45* < 0.001
ALT (U/L) 46 (27.5–65) ** 41.72 ± 9.66* 0.15
AST (U/L) 45.28 ± 22.4* 40.88 ± 12.09* 0.39
Creatinine (mg/dl) 1 (0.8–1.03) ** 1.3 (1–1.75) ** 0.001
AFP (ng/ml) 4.5 (3.2–6.65) ** 311.4 ± 209.43* < 0.001
VEGF (ng/ml) 209.5 ± 137.6* 488.01 ± 194.5* < 0.001
  1. *Data represented in terms of mean ± SD
  2. **Data represented in terms of median (Q1–Q3)
  3. #Data represented in terms of frequency (percentage), n (%)